Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029423981> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2029423981 endingPage "46" @default.
- W2029423981 startingPage "44" @default.
- W2029423981 abstract "Consolidation therapy is used in order to maximize the benefit of first-line therapy and to improve the progression-free and overall survival of patients. In women with advanced epithelial ovarian cancer, tested maintenance and consolidation strategies following first-line chemotherapy include high-dose chemotherapy, radiation therapy, intraperitoneal radionuclides including those linked to an antibody, and biological and immunologic agents. This review focuses on the current understanding of the benefit of radiation therapy and biological agents used as consolidation in women with advanced ovarian cancer. Whole abdominal radiation has given promising results only in the subgroup of patients with pathologic complete response. However, this treatment modality is associated with considerable intestinal toxicity. Single treatment with intraperitoneal radionuclides, either alone ( 32 P) or in combination with an antibody ( 90 Y-muHMFG1) has not improved survival. Biological agents used for consolidation include, eg, α- and γ-interferon, tanomastat, a matrix metalloprotease inhibitor and oregovomab, a murine antibody that targets CA125. Randomized trials with these agents have not demonstrated any significant improvement in the overall survival of ovarian cancer patients. Currently, two ongoing studies (GOG 218, ICON7) are examining the potential of bevacizumab in the maintenance therapy of advanced epithelial ovarian cancer. Evaluation of new agents is indicated in order to achieve long-term disease-free survival in these patients. Toxicity and ease of administration must be reflected against the benefits of therapy." @default.
- W2029423981 created "2016-06-24" @default.
- W2029423981 creator A5005455563 @default.
- W2029423981 creator A5017337687 @default.
- W2029423981 date "2008-01-01" @default.
- W2029423981 modified "2023-10-15" @default.
- W2029423981 title "Radiation therapy and biological compounds for consolidation therapy in advanced ovarian cancer" @default.
- W2029423981 cites W1590342103 @default.
- W2029423981 cites W1996029150 @default.
- W2029423981 cites W2024894561 @default.
- W2029423981 cites W2026017442 @default.
- W2029423981 cites W2044147848 @default.
- W2029423981 cites W2054426851 @default.
- W2029423981 cites W2059321723 @default.
- W2029423981 cites W2061399161 @default.
- W2029423981 cites W2094276758 @default.
- W2029423981 cites W2094558779 @default.
- W2029423981 cites W2115451334 @default.
- W2029423981 cites W2132731224 @default.
- W2029423981 cites W2165628351 @default.
- W2029423981 doi "https://doi.org/10.1111/j.1525-1438.2007.01105.x" @default.
- W2029423981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18336400" @default.
- W2029423981 hasPublicationYear "2008" @default.
- W2029423981 type Work @default.
- W2029423981 sameAs 2029423981 @default.
- W2029423981 citedByCount "5" @default.
- W2029423981 countsByYear W20294239812023 @default.
- W2029423981 crossrefType "journal-article" @default.
- W2029423981 hasAuthorship W2029423981A5005455563 @default.
- W2029423981 hasAuthorship W2029423981A5017337687 @default.
- W2029423981 hasConcept C121608353 @default.
- W2029423981 hasConcept C126322002 @default.
- W2029423981 hasConcept C143998085 @default.
- W2029423981 hasConcept C2776694085 @default.
- W2029423981 hasConcept C2777802072 @default.
- W2029423981 hasConcept C2779387952 @default.
- W2029423981 hasConcept C2780427987 @default.
- W2029423981 hasConcept C509974204 @default.
- W2029423981 hasConcept C71924100 @default.
- W2029423981 hasConceptScore W2029423981C121608353 @default.
- W2029423981 hasConceptScore W2029423981C126322002 @default.
- W2029423981 hasConceptScore W2029423981C143998085 @default.
- W2029423981 hasConceptScore W2029423981C2776694085 @default.
- W2029423981 hasConceptScore W2029423981C2777802072 @default.
- W2029423981 hasConceptScore W2029423981C2779387952 @default.
- W2029423981 hasConceptScore W2029423981C2780427987 @default.
- W2029423981 hasConceptScore W2029423981C509974204 @default.
- W2029423981 hasConceptScore W2029423981C71924100 @default.
- W2029423981 hasIssue "Suppl 1" @default.
- W2029423981 hasLocation W20294239811 @default.
- W2029423981 hasLocation W20294239812 @default.
- W2029423981 hasOpenAccess W2029423981 @default.
- W2029423981 hasPrimaryLocation W20294239811 @default.
- W2029423981 hasRelatedWork W2089609493 @default.
- W2029423981 hasRelatedWork W2347272611 @default.
- W2029423981 hasRelatedWork W2347438058 @default.
- W2029423981 hasRelatedWork W2349204430 @default.
- W2029423981 hasRelatedWork W2353276349 @default.
- W2029423981 hasRelatedWork W2376538688 @default.
- W2029423981 hasRelatedWork W2387970634 @default.
- W2029423981 hasRelatedWork W2417555288 @default.
- W2029423981 hasRelatedWork W3211657369 @default.
- W2029423981 hasRelatedWork W4225091507 @default.
- W2029423981 hasVolume "18" @default.
- W2029423981 isParatext "false" @default.
- W2029423981 isRetracted "false" @default.
- W2029423981 magId "2029423981" @default.
- W2029423981 workType "article" @default.